Pepper Bio, the world's first transomics drug discovery company, leverages its proprietary database and analytics to identify promising first-in-class therapies, rediscover new uses for existing therapeutics, and rescue drugs in development on a path toward failure. By deciphering the root causes of diseases to identify effective treatments, Pepper Bio illuminates the fastest, safest path to drug discovery. Its AI-driven platform, COMPASS, is built on the world's first and largest proprietary transomics database, integrating genomic, transcriptomic, proteomic, and phosphoproteomic data. This holistic approach offers a full-picture understanding of biological systems—like driving using all your mirrors to know the impact of where other cars are on the road. Unlike other companies that focus on measuring gene and protein expression levels, Pepper Bio not only identifies what's present in a disease but also understands the activities and reasons behind these occurrences.